Gossamer Bio
(NASDAQ) GOSS
Gossamer Bio Financials at a Glance
Market Cap
$89.54M
Revenue (TTM)
$48.47M
Net Income (TTM)
$170.37M
EPS (TTM)
$-0.75
P/E Ratio
-0.51
Dividend
$0.00
Beta (Volatility)
1.94 (High)
Dividend
$0.00
Beta (Volatility)
1.94 (High)
Price
$0.38
Volume
198,083
Open
$0.36
Price
$0.38
Volume
198,083
Open
$0.36
Previous Close
$0.38
Daily Range
$0.35 - $0.40
52-Week Range
$0.32 - $3.87
Dividend
$0.00
Beta (Volatility)
1.94 (High)
Price
$0.38
Volume
198,083
Open
$0.36
Previous Close
$0.38
Daily Range
$0.35 - $0.40
52-Week Range
$0.32 - $3.87
GOSS News
Is Gossamer Bio a Buy?
GOSS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Gossamer Bio
Industry
Biotechnology
Sector
Health CareEmployees
162
CEO
Faheem Hasnain
Website
www.gossamerbio.comHeadquarters
San Diego, CA 92121, US
GOSS Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-4%
Net Income Margin
-4%
Return on Equity
-783%
Return on Capital
-2%
Return on Assets
-99%
Earnings Yield
-1.96%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$89.54M
Shares Outstanding
234.70M
Volume
198.08K
Short Interest
0.00%
Avg. Volume
15.52M
Financials (TTM)
Gross Profit
$47.47M
Operating Income
$163.25M
EBITDA
$162.25M
Operating Cash Flow
$171.27M
Capital Expenditure
$79.00K
Free Cash Flow
$171.34M
Cash & ST Invst.
$136.93M
Total Debt
$201.97M
Gossamer Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$13.80M
+47.1%
Gross Profit
$13.57M
+44.7%
Gross Margin
98.35%
N/A
Market Cap
$89.54M
N/A
Market Cap/Employee
$621.78K
N/A
Employees
144
N/A
Net Income
$47.24M
-43.0%
EBITDA
$45.81M
-44.9%
Quarterly Fundamentals
Net Cash
$65.04M
-171.0%
Accounts Receivable
$12.53M
+134.7%
Inventory
$0.00
N/A
Long Term Debt
$201.97M
+0.0%
Short Term Debt
$938.00K
-2.4%
Return on Assets
-98.91%
N/A
Return on Invested Capital
-1.57%
N/A
Free Cash Flow
$48.31M
-36.2%
Operating Cash Flow
$48.31M
-36.2%